Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PDT Pharma is a Brazilian pharmaceutical company specializing in the development and production of photosensitizers and equipment for Photodynamic Therapy (PDT). Founded in 2006 and headquartered in Cravinhos, São Paulo, the company is a pioneer in the domestic production of Photodithazine, a second-generation photosensitizer used primarily in oncology and dermatology. Their business model encompasses the entire value chain, from R&D and chemical synthesis to the manufacturing of finished dosage forms and medical devices. PDT Pharma also operates as a Contract Manufacturing Organization (CMO), providing specialized services for sterile and non-sterile pharmaceutical products. The company maintains strong ties with academic institutions like the University of São Paulo to advance clinical applications of PDT in treating skin cancer and infectious diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PDT Pharma.